-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Import duties and VAT / sales tax
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Performance Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
-
Monitoring and Evaluation
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- M&E Components of Grant Implementation
- Monitoring and Evaluation Components of Grant Making
- Overview
- Principal Recipient Start-Up
-
Health Product Management
- UNDP Quality Assurance Policy
- Compliance with the Global Fund requirements
- Distribution
- Inspection and Receipt
- International freight, transit requirements and use of INCOTERMS
- Inventory Management
- Overview - Health Product Management
- Pharmacovigilance
- Product Selection
- Quality monitoring of health products
- Quantification and Forecasting
- Rational use
- Risk Management for PSM of health products
-
Sourcing and regulatory aspects
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Global Health Procurement Center (GHPC)
- Guidance on donations of health products
- Health Procurement Architecture
- Local Procurement of health products
- Other Elements of the UNDP Procurement Architecture
- Procurement of non-pharmaceutical Health Products
- Procurement of Pharmaceutical Products
- Submission of GHPC CO Procurement Request Form
- Storage
- Supply Planning of Health Products
- UNDP Health PSM Roster
- Waste management
- Grant Reporting
-
Risk Management
- Introduction to Risk Management
- Overview
- Risk management in crisis settings
-
Risk Management in the Global Fund
- Additional Safeguard Policy
- Challenging Operating Environment (COE) Policy
- Global Fund Review of Risk Management During Grant Implementation
- Global Fund Risk Management Framework
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Risk Management Requirements for PRs
- Local Fund Agent
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Sub-Recipient Management
Gender
HIV: Adolescent girls and young women aged 15–24 years are at particularly high risk of HIV infection. Gender inequality has direct implications for women’s and girls’ risks of acquiring HIV. Women and girls account for 48 percent of new HIV infections worldwide and 59 percent of new infections in sub-Saharan Africa, and AIDS remains one of the leading causes of death for women aged 15–49 years globally.
Harmful gender norms and inequalities, insufficient access to education and sexual and reproductive health services, poverty, food insecurity and violence, are at the root of this increased HIV risk for young women and adolescent girls. Gender-based violence has significant implications for women’s and girls’ risks of acquiring HIV and impairs their ability to cope with the virus. Gender inequalities and norms also substantially increase the risks faced by women and girls who belong to other key populations. In low- and middle-income countries worldwide it is estimated that female sex workers are more than 13 times more likely than the general population to be HIV-positive. Transgender women are particularly vulnerable to HIV, having almost 50 times the odds of having HIV than the general population worldwide. Similarly, women who inject drugs are at higher risk of HIV compared to men who use drugs. As mentioned above, these key populations are also criminalized, creating further barriers to accessing health services. TB and HIV co-infection also increases women’s health risks. Women from these key populations living with HIV are highly susceptible to developing active TB during pregnancy or soon after delivery, making TB a leading cause of death during pregnancy and delivery, and thereafter.
TB: Gender analysis and gender-responsive programming is comparatively new to the field of TB. Considerable debate on the gender divide in TB persists at all levels: medical research is divided on the ways in which TB symptoms in men and women differ, and there is inadequate medical data on women’s experience of TB in particular. The impact of TB on pregnancy is under-researched. Environmental contributions to women’s and men’s TB infection rates are ill understood. Studies of women’s and men’s differential access to TB health services have produced a range of contradictory findings, with little consensus on whether or not gender barriers to TB services access exist, and incomplete explanations for those gender differences that have been identified.
Malaria: Evidence indicates that malaria transmission is determined in large part by social, economic and cultural factors that intersect with sex-specific and gender-specific vulnerabilities. These vulnerabilities are largely still under-researched and not considered in programmatic responses. Gaps in our understanding are important to explore further, as they address deeper gender inequalities, and interventions that address the structural drivers of the disease are likely to be more effective and sustainable. Investment to address the social determinants of malaria has the potential to significantly move forward our understanding of the disease, and target interventions towards the most vulnerable.
Additional guidance to support this area of work are also available through a number of resources listed below:
Loading resources
